|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-11-03 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 14-11-03 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2023-03-05 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 2011-05-30 |
Stephen Street
PRN | Corporate Officer/Principal | 65 | 2012-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 2015-02-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.09% | +5.26% | +4.44% | +26.03% | 51.22B | |
| -1.19% | +2.20% | +470.70% | +596.99% | 45.38B | |
| +1.47% | +8.08% | +19.62% | +91.50% | 41.97B | |
| +1.65% | +9.70% | +40.04% | +21.12% | 42.15B | |
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | |
| -0.65% | +3.04% | - | - | 16.73B | |
| +1.37% | +7.55% | +37.24% | +152.94% | 17.1B | |
| +0.03% | +3.91% | +5.84% | +35.04% | 14.76B | |
| +1.35% | +5.88% | +91.86% | +47.58% | 13.91B | |
| Average | +0.48% | +3.19% | +85.89% | +127.22% | 30.58B | |
| Weighted average by Cap. | +0.50% | +3.13% | +103.14% | +148.73% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
